id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-N-4821-0001,FDA,FDA-2024-N-4821,"Food and Drug Administration’s Best Practices for Food and Drug Administration Communication With
Interested Parties: Draft Report for Public Comment; Availability",Notice,Notice of Availability,2024-12-03T05:00:00Z,2024,12,2024-12-03T05:00:00Z,,2024-12-03T14:28:39Z,2024-28229,0,0,0900006486846ee3
FDA-2024-N-4821-0002,FDA,FDA-2024-N-4821,Best Practices for Food and Drug Administration Communication With Interested Parties: Draft Report for Public Comment,Other,Report,2024-12-03T05:00:00Z,2024,12,2024-12-03T05:00:00Z,2025-02-04T04:59:59Z,2025-02-04T02:01:11Z,,1,0,09000064868471cb